chr9-136370436-T-A

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_052813.5(CARD9):​c.809A>T​(p.Glu270Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00397 in 1,610,598 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0037 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0040 ( 25 hom. )

Consequence

CARD9
NM_052813.5 missense, splice_region

Scores

19
Splicing: ADA: 0.000004033
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 1.14
Variant links:
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040002167).
BP6
Variant 9-136370436-T-A is Benign according to our data. Variant chr9-136370436-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 365844.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=1}. Variant chr9-136370436-T-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0037 (564/152270) while in subpopulation AMR AF= 0.00712 (109/15300). AF 95% confidence interval is 0.00604. There are 3 homozygotes in gnomad4. There are 288 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD9NM_052813.5 linkc.809A>T p.Glu270Val missense_variant, splice_region_variant Exon 6 of 13 ENST00000371732.10 NP_434700.2 Q9H257-1A0A024R8F1
CARD9NM_052814.4 linkc.809A>T p.Glu270Val missense_variant, splice_region_variant Exon 6 of 13 NP_434701.1 Q9H257-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD9ENST00000371732.10 linkc.809A>T p.Glu270Val missense_variant, splice_region_variant Exon 6 of 13 1 NM_052813.5 ENSP00000360797.5 Q9H257-1
ENSG00000289701ENST00000696169.1 linkn.809A>T splice_region_variant, non_coding_transcript_exon_variant Exon 6 of 13 ENSP00000512460.1

Frequencies

GnomAD3 genomes
AF:
0.00370
AC:
563
AN:
152154
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.00713
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.00497
Gnomad OTH
AF:
0.00717
GnomAD3 exomes
AF:
0.00354
AC:
862
AN:
243526
Hom.:
4
AF XY:
0.00391
AC XY:
518
AN XY:
132534
show subpopulations
Gnomad AFR exome
AF:
0.000324
Gnomad AMR exome
AF:
0.00316
Gnomad ASJ exome
AF:
0.000911
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00409
Gnomad FIN exome
AF:
0.00223
Gnomad NFE exome
AF:
0.00489
Gnomad OTH exome
AF:
0.00608
GnomAD4 exome
AF:
0.00400
AC:
5838
AN:
1458328
Hom.:
25
Cov.:
33
AF XY:
0.00405
AC XY:
2940
AN XY:
725362
show subpopulations
Gnomad4 AFR exome
AF:
0.000838
Gnomad4 AMR exome
AF:
0.00339
Gnomad4 ASJ exome
AF:
0.000422
Gnomad4 EAS exome
AF:
0.0000505
Gnomad4 SAS exome
AF:
0.00466
Gnomad4 FIN exome
AF:
0.00271
Gnomad4 NFE exome
AF:
0.00433
Gnomad4 OTH exome
AF:
0.00405
GnomAD4 genome
AF:
0.00370
AC:
564
AN:
152270
Hom.:
3
Cov.:
34
AF XY:
0.00387
AC XY:
288
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.000650
Gnomad4 AMR
AF:
0.00712
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00352
Gnomad4 FIN
AF:
0.00292
Gnomad4 NFE
AF:
0.00497
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.00439
Hom.:
1
Bravo
AF:
0.00365
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00431
AC:
37
ExAC
AF:
0.00350
AC:
423
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Predisposition to invasive fungal disease due to CARD9 deficiency Uncertain:1Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CARD9 NM_052813.4 exon 6 p.Glu270Val (c.809A>T): This variant has not been reported in the literature but is present in 0.4% (601/123300) of European alleles, including 3 homozygotes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs114895119). This variant is present in ClinVar (Variation ID:365844). This variant amino acid Valine (Val) is present in >15 species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. Splice prediction tools suggest that this variant may affect splicing. However, further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

CARD9-related disorder Benign:1
Jul 11, 2023
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CARD9: BP4, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
17
DANN
Benign
0.86
DEOGEN2
Benign
0.079
.;T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.76
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.57
T;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.0040
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;L
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.040
Sift
Benign
0.27
T;T
Sift4G
Benign
0.24
T;T
Polyphen
0.0040
B;B
Vest4
0.28
MVP
0.16
MPC
0.092
ClinPred
0.0013
T
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.090
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000040
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114895119; hg19: chr9-139264888; COSMIC: COSV105139145; COSMIC: COSV105139145; API